NCT04259203Completed
Efficacy of Ericksonian Hypnosis in the Management of Chronic Pain Related to Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 5 Dec 2025
Brief summary (registry, in English)
This study evaluates the efficacity of Erickson hypnosis in the treatment of chronic pain in patients with Parkinson's disease. Half of participants will follow a 2-month Erickson hypnosis protocole, while the other half will benefit from the usual care.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 33 (actual)
- First submitted
- 4 Feb 2020
- Start date
- 8 Aug 2020
- Primary completion date
- 16 Aug 2024
- Lead sponsor
- University Hospital, Lille
- Diseases
- Parkinson disease
- NCT number
- NCT04259203
What you commit to
- Study type: Interventional
- Participants enrolled: 33
- From 8 Aug 2020 to the primary completion date, 16 Aug 2024
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patient with a neurological condition other than Parkinson's disease or with an atypical Parkinson's syndrome
- Patient whose pain is mainly attributable to another pathology (rheumatoid arthritis, spondyloarthritis ankylosing, diabetic neuropathy, cancer, etc.)
- Patient with cognitive impairment objectified by a score at the Montreal Cognitive Assessment (MoCA) \<24
Other
- Early untreated patient
- Patient with acute intercurrent pain
- Patient with hallucinations and/or psychosis (MDS-UPDRS 1.2\> 1)
- Patient with a apathy (MDS-UPDRS 1.5\> 1)
- Patient with disabling dyskinesia (MDS-UPDRS) 4.1 AND 4.2\> 1)
- Patient under the protection of adults
- Pregnant or lactating woman
Who the study is looking for
- Men or women
- 18 to 80 years old
- idiopathic Parkinson's disease
- without neurological co-morbidity
- Suffering from chronic pain (for at least 3 months), related to Parkinson's disease
- Having a pain intensity of at least 30 mm on the VAS (average intensity over the previous week) for Parkinson's disease-related pain
- antiparkinsonian, analgesic and psychotropic treatments stable for 1-month
- having a health insurance
- signed informed consent form
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Côte de Nacre Coordinator of this site? Confirm its status | Caen | France | Unknown status |
| Hôpital Roger Salengro (CHRU de Lille) Coordinator of this site? Confirm its status | Lille | France | Unknown status |
| Hopital Charles Nicolle Chu Rouen Coordinator of this site? Confirm its status | Rouen | France | Unknown status |
| Hopital Purpan Chu Toulouse Coordinator of this site? Confirm its status | Toulouse | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.